Search research articles
Contact Us
Filters
Showing results (241-250 of 256) with videos related to
Page
of 26
Sort By:
Journal of Medicinal Chemistry
|
September 1, 2006
Design, synthesis, and biophysical and biological evaluation of a series of pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugates
Geoff Wells, Christopher R H Martin, Philip W Howard, et al.
Scientific Reports
|
July 12, 2018
Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine
John A Hartley, Michael J Flynn, John P Bingham, et al.
The American Journal of Surgical Pathology
|
April 21, 2026
Discontinuous Involvement of the Spermatic Cord by Germ Cell Tumors Should Not Be Considered Pathologic Stage M1: An International Multi-Institutional Study
João Lobo, Dheeraj Chinnam, Kvetoslava Michalova, et al.
Molecular Cancer Therapeutics
|
March 3, 2021
Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR
Shenlan Mao, Raghothama Chaerkady, Wen Yu, et al.
The Journal of Sexual Medicine
|
June 25, 2026
Impact of testosterone therapy and hypogonadism on treatment outcomes in Peyronie's disease: a multicenter retrospective analysis of collagenase clostridium histolyticum therapy
Beatriz S Hernandez, Arnaav Walia, Peyton Coady, et al.
Molecular Cancer Therapeutics
|
August 19, 2016
ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies
Michael J Flynn, Francesca Zammarchi, Peter C Tyrer, et al.
JCO Precision Oncology
|
March 2, 2026
Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors
Rebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.
JCO Precision Oncology
|
September 24, 2025
Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors
Rebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.
Journal of Medicinal Chemistry
|
November 8, 2017
Pyrrolobenzodiazepine Dimer Antibody-Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers
Stephen J Gregson, Luke A Masterson, Binqing Wei, et al.
Sexual Medicine
|
May 6, 2026
Efficacy and safety of collagenase <i>Clostridium histolyticum</i> in men who have sex with men
Jake A Miller, Muhammed A Moukhtar Hammad, Lucas G C R de Amorim, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 256) with videos related to
Sort By:
Page
of 26
Journal of Medicinal Chemistry
|
September 1, 2006
Design, synthesis, and biophysical and biological evaluation of a series of pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugates
Geoff Wells, Christopher R H Martin, Philip W Howard, et al.
Scientific Reports
|
July 12, 2018
Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine
John A Hartley, Michael J Flynn, John P Bingham, et al.
The American Journal of Surgical Pathology
|
April 21, 2026
Discontinuous Involvement of the Spermatic Cord by Germ Cell Tumors Should Not Be Considered Pathologic Stage M1: An International Multi-Institutional Study
João Lobo, Dheeraj Chinnam, Kvetoslava Michalova, et al.
Molecular Cancer Therapeutics
|
March 3, 2021
Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR
Shenlan Mao, Raghothama Chaerkady, Wen Yu, et al.
The Journal of Sexual Medicine
|
June 25, 2026
Impact of testosterone therapy and hypogonadism on treatment outcomes in Peyronie's disease: a multicenter retrospective analysis of collagenase clostridium histolyticum therapy
Beatriz S Hernandez, Arnaav Walia, Peyton Coady, et al.
Molecular Cancer Therapeutics
|
August 19, 2016
ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies
Michael J Flynn, Francesca Zammarchi, Peter C Tyrer, et al.
JCO Precision Oncology
|
March 2, 2026
Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors
Rebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.
JCO Precision Oncology
|
September 24, 2025
Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors
Rebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.
Journal of Medicinal Chemistry
|
November 8, 2017
Pyrrolobenzodiazepine Dimer Antibody-Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers
Stephen J Gregson, Luke A Masterson, Binqing Wei, et al.
Sexual Medicine
|
May 6, 2026
Efficacy and safety of collagenase <i>Clostridium histolyticum</i> in men who have sex with men
Jake A Miller, Muhammed A Moukhtar Hammad, Lucas G C R de Amorim, et al.
Page
of 26